Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What dose constraints, if any, do you use for the thyroid gland when treating with regional nodal irradiation for breast cancer?
Answer from: Radiation Oncologist at Community Practice
I have not used any constraints for thyroid for RNI but based on the volume, dose is confined to ipsilateral lobe of thyroid.
Sign in or Register to read more
5899
Related Questions
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
For a young female (<40) with HR-/HER2+ cT1-2N1, ypT1aN0 s/p mastectomy with SLNB, would you offer PMRT?
How do your PMRT recommendations change with ITCs after neoadjuvant chemotherapy if they had SLNB only versus ALND in light of B51?
When should the dissected axilla (levels I-II) be included when delivering RNI?
Would you consider partial breast irradiation in patients who otherwise meet PBI guidelines who have a pathogenic variant of CHEK2 or other moderate penetrance gene?
What are your top takeaways in Breast Cancer from ASTRO 2024?
Under what circumstances would you offer PMRT in a patient with DCIS?